Overview

Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets

Status:
COMPLETED
Trial end date:
2024-09-25
Target enrollment:
Participant gender:
Summary
This is a A single-center, randomized, open-label, two-dose, two-period, crossover trial was conducted to evaluate the effect of food on the Pharmacokinetic characteristics and safety of oral administration of LPM3770164 sustained-release tablets 30 mg in healthy subjects.
Phase:
PHASE1
Details
Lead Sponsor:
Luye Pharma Group Ltd.